NASDAQ OMX

Percona Announces Full Conference Schedule for Percona Live Open Source Database Conference Europe 2017

Dela

RALEIGH, N.C., Sept. 06, 2017 (GLOBE NEWSWIRE) -- Percona, the company that delivers enterprise-class MySQL®, MongoDB® and other open source database solutions and services, today unveiled the full conference schedule for Percona Live Open Source Database Conference Europe 2017, taking place September 25-27, 2017 at the Radisson Blu Royal Hotel in Dublin, Ireland. The Advanced Registration Discount rate expires on September 5, 2017. Sponsorship opportunities are still available.

The Percona Live Open Source Database Conference Europe, which was completely sold-out in 2016, is the premier event for individuals and businesses developing and using open source software.

The conference theme this year is "Championing Open Source Databases," with sessions on MySQL, MariaDB, MongoDB and other open source database technologies, including time series databases, PostgreSQL and RocksDB. The 2017 conference will feature a range of keynote addresses, in-depth discussions and hands-on tutorials for three formal tracks - Developer, Business/Case Studies and Operations.

The conference includes more than 100 keynotes, tutorials and breakout sessions. A sampling of each includes:

Keynote Addresses
Tuesday, September 26, 2017

  • Championing Open Source Databases - Peter Zaitsev (Percona)
  • PMM Demo - Michael Coburn (Percona)
  • MySQL as a Layered Service: How to Use ProxySQL to Control Traffic and Scale Out - Rene Cannao (ProxySQL)
  • Real Time DNS Analytics at Cloudflare with ClickHouse - Tom Arnfeld (Cloudflare)
  • Why Open Sourcing Our Database Tooling Was the Smart Decision - Shlomi Noach (GitHub)
  • MyRocks at Facebook and a Roadmap - Yoshinori Matsunobu (Facebook)
  • Prometheus for Monitoring Metrics - Brian Brazil (Prometheus/Robust Perception)

Wednesday, September 27, 2017

  • State of the Dolphin - Geir Høydalsvik (Oracle)
  • Q&A with the authors of "Database Reliability Engineering" - Laine Campbell (Fastly/OpsArtisan) and Charity Majors (Honeycomb)
  • Many Faces of Continuent Tungsten - MC Brown (Continuent)
  • Customer Keynote: Database Performance in High Traffic Environments - Pavel Genov (Pepper)

Tutorials
Monday, September 25, 2017

Breakout Sessions
Tuesday, September 26, 2017  

MySQL/MariaDB

MongoDB

Open Source Databases

Wednesday, September 27, 2017

MySQL/MariaDB

MongoDB

Open Source Databases

Sponsorships
Sponsor ship opportunities for the Percona Live Open Source Database Conference Europe 2017 are available and offer the opportunity to interact with DBAs, sysadmins, developers, CTOs, CEOs, business managers, technology evangelists, solution vendors, and entrepreneurs who typically attend the event. Current sponsors include:

Diamond Sponsor - Continuent
Gold Sponsors - Facebook, VividCortex
Exhibitor Sponsors - Altinity, Ispirer, PGDAY Russia '17, Rackspace, Severalnines, TimescaleDB
Contributor Sponsors - Webyog, Oracle MySQL
Media Sponsors - CMSWire, Datanami, InsideBigData, InsideHPC, ODBMS.org, Opensource.com, O'Reilly Media

Eero Teerikorpi, Founder & CEO, Continuent
"Continuent is very excited to once again be participating as a Diamond Sponsor in Percona Live Europe, the premier open source database conference," said Eero Teerikorpi, Founder and CEO, Continuent Ltd. "The event is an excellent meeting place for Europe's diverse open source database community who use Tungsten Clustering, our state-of-the-art MySQL clustering solution for multi-site, multi-master deployments, and Tungsten Replicator for real-time data loading into analytics."

Percona Live Conferences

What:    Percona Live Open Source Database Conference Europe 2017 
Where:   Radisson Blu Royal Hotel, 8 Golden Lane, Dublin, Ireland
When:     September 25-27, 2017        


About Percona

With more than 3,000 customers worldwide, Percona is the only company that delivers enterprise-class solutions for both MySQL®, MongoDB® and other open source databases across traditional and cloud-based platforms. The company provides SoftwareSupport,  Consulting, and Managed Services to large, well-known global brands such as Cisco Systems, Time Warner Cable, Alcatel-Lucent, Rent the Runway and the BBC, as well as smaller enterprises looking to maximize application performance while streamlining database efficiencies. Well established as thought leaders, Percona experts author content for the Percona Database Performance Blog and the Percona Live Open Source Database Conferencesdraw attendees and expert technical speakers from around the world. For more information, visit www.percona.com.

Percona®, XtraBackup®, TokuDB® and Fractal Tree® are registered trademarks of Percona LLC or its subsidiaries. All other registered and unregistered trademarks in this document are the sole property of their respective owners.

 

Company Information

Press Contact
Brigit Valencia
For Percona
(360) 597-4516
bdbvalencia@gmail.com



This announcement is distributed by Nasdaq Corporate Solutions on behalf of Nasdaq Corporate Solutions clients.
The issuer of this announcement warrants that they are solely responsible for the content, accuracy and originality of the information contained therein.
Source: Percona via Globenewswire

Om

NASDAQ OMX
NASDAQ OMX



Följ NASDAQ OMX

Skriv in din e-postadress så får du ett mejl när vi har något nytt att berätta.

Senaste pressmeddelandena från NASDAQ OMX

XBiotech to Present at Cantor Fitzgerald's Global Healthcare Conference21.9.2017 14:00Pressmeddelande

AUSTIN, Texas, Sept.  21, 2017  (GLOBE NEWSWIRE) -- XBiotech Inc. (NASDAQ:XBIT) announced today that management will be presenting at Cantor Fitzgerald's Global Healthcare Conference taking place September 25-27 at the InterContinental New York Barclay Hotel in New York City. Mr. Benjamin Guzman, the Company's Senior Vice President of Corporate Strategy & Finance, will provide a corporate overview on Wednesday, September 27th at 2:50pm Eastern Time. About True Human(TM) Therapeutic Antibodies Unlike previous generations of antibody therapies, XBiotech's True Human(TM) antibodies are derived without modification from individuals who possess natural immunity to certain diseases. With discovery and clinical programs across multiple disease areas, XBiotech's True Human antibodies have the potential to harness the body's natural immunity to fight disease with increased safety, efficacy and tolerability. About XBiotech

At the 10th anniversary of the iPhone, Chairman of Pilatus Bank draws a stark comparison of the role technology has played in banking vs telecommunication21.9.2017 08:58Pressmeddelande

LONDON, Sept. 21, 2017 (GLOBE NEWSWIRE) -- Ali Sadr, Chairman of Pilatus Bank, believes that banks have failed to capture the true essence of technology for improving quality of service, as well as lacking the vision necessary to capture customers' imaginations. Meanwhile, other industries have been revolutionized and continue to thrive by the same technology. America has in the last 10 years been forced to close 10,000 branches. Since 2008, Europe has lost close to 48,000 branches, which is more than 20% of its branch network. There is little doubt that branch banking is on the decline, and online banking is failing to provide a quality service.  As we mark the 10th anniversary of the iPhone, Ali Sadr, Chairman of Pilatus Bank, gives a sobering count of the current state of affairs in the use of technology among well established banks, and elaborates on a vision that has the potential to become the largest revolution the banking industry is yet to experience. Chairman Al

Immunicum AB (publ) presenterar prekliniska data om ilixadencels verkningsmekanism på SITC-mötet i USA21.9.2017 08:00Pressmeddelande

Pressmeddelande 21 september 2017 Immunicum AB (publ) presenterar prekliniska data om ilixadencels verkningsmekanism på SITC-mötet i USA Immunicum AB (publ; First North Premier: IMMU.ST), ett bioteknikbolag som utvecklar nya immunostimulerande cancerbehandlingar för ett antal solida tumörer, meddelar idag att Society for Immunotherapy of Cancer (SITC) har accepterat att ett abstract kring ilixadencels verkningsmekanism presenteras som poster vid SITCs 32:a årsmöte som hålls 8-12 november, 2017 i Gaylord National Hotel & Convention Center i National Harbor, Maryland. Postern med titeln "In vitro mode of action of ilixadencel - a cell-based allogeneic immune primer for intratumoral administration" presenteras av Immunicums forskningschef Alex Karlsson-Parra. Immunicum kommer att offentliggöra fullständiga data i ett pressmeddelande efter presentationen. När datum och tidpunkt för presentationen offentliggjorts kommer detta att fi

Immunicum AB (publ) to Present Preclinical Data on Ilixadencel's Mode of Action at the SITC Meeting in the US21.9.2017 08:00Pressmeddelande

Press Release 21 September 2017 Immunicum AB (publ) to Present Preclinical Data on Ilixadencel's Mode of Action at the SITC Meeting in the US Immunicum AB (publ; First North Premier: IMMU.ST) a biopharmaceutical company advancing a novel immune-priming cancer treatment against a variety of solid tumors, today announced that the Society for Immunotherapy of Cancer (SITC) has accepted an abstract on ilixadencel's mode of action for a poster presentation at the SITC 32 nd Annual Meeting, held November 8-12, 2017 at the Gaylord National Hotel & Convention Center in National Harbor, Maryland. The poster titled "In vitro mode of action of ilixadencel - a cell-based allogeneic immune primer for intratumoral administration" will be presented by Immunicum's Chief Scientific Officer, Alex Karlsson-Parra. Immunicum will announce the complete data through a press relea

Asure Software to Attend at Quora Consulting's Smartworking Summit21.9.2017 07:00Pressmeddelande

Asure Join's Industry Leaders to Discuss "Understanding the Productivity Enigma" AUSTIN, Texas, Sept. 21, 2017 (GLOBE NEWSWIRE) -- Asure Software, (NASDAQ:ASUR), a leading provider in human capital management and workspace management software, will be sponsoring Quora Consulting's Smartworking Summit in central London, September 28th 2017. These summits have continued to lead in addressing work space issues, such as occupancy, utilization, and productivity in the workforce. Dominic Jackson, Asure Sales Director of EMEA commented, "It is workplace issues like productivity that have driven thought leadership here at Asure." He continued "Utilization of workspace solutions help you recruit and retain the best talent, improve employee productivity, streamline operations, and realize a significant ROI on your most valuable assets - people, space and technology. We are thrilled to be not only part of the discussion, but part of the solu

Abiomed Receives FDA PMA Approval for Impella RP® for Right Heart Failure21.9.2017 00:23Pressmeddelande

DANVERS, Mass., Sept.  20, 2017  (GLOBE NEWSWIRE) -- Abiomed, Inc. (NASDAQ:ABMD), a leading provider of breakthrough heart support and recovery technologies, today announced it has received U.S. Food and Drug Administration (FDA) pre-market approval (PMA) for the Impella RP® heart pump. Culminating from five years of research, this approval follows the prior FDA Humanitarian Device Exemption (HDE) received in January 2015 and adds the Impella RP heart pump to Abiomed's platform of PMA approved devices. With this approval, the Impella RP heart pump is the only percutaneous temporary ventricular support device that is FDA-approved as safe and effective for right heart failure as stated in the indication: The Impella RP System is indicated for providing temporary right ventricular support for up to 14 days in patients with a body surface area greater than or equal to 1.5 m2, who develop acute right heart failure or decompensation following left ventricular assist device impl

I vårt pressrum kan du läsa de senaste pressmeddelandena, få tillgång till pressmaterial och hitta kontaktinformation.

Besök vårt pressrum